Since 2004, Innovative Diagnostics (ID) develops, produces and sells ELISA, PCR and rapid tests to diagnose infectious zoonotic and veterinary diseases. 

Over 130 employees work in our 4000 m² headquarters at the heart of the “MED Valley” of Montpellier, France.
ID has shown continuous growth over the years and offers a wide range of veterinary tests sold in over 100 countries under the brand name IDvet. 

ID is an actor of the One Health approach, which recognizes that human and animal health are interdependent. We contribute to securing the global health and food supply, thanks to the control of zoonotic and veterinary diseases. Further to the emergence of COVID-19, we quickly developed COVID-19 ELISA tests detecting IgG, IgA and IgM in sera, and an immunochromatographic test for nasopharyngeal swabs.

“With you at every step” is our motto. To improve global supply and assistance, we have a training center in Jordan, offices in Brazil, India, China, and a production facility in the USA.

In 2016, we contributed to creating ID Solutions (www.id-solutions.fr) to provide tools to detect oncogenic mutations in human circulating DNA by dPCR.
When COVID-19 emerged, ID made its know-how, industrial infrastructures, staff and financial resources available to ID Solutions in order to develop and produce COVID-19 PCR kits for use in humans, allowing ID Solutions to become a major COVID PCR kit manufacturer in France. ID left ID Solutions presidency in December 2021 and sold all its shares in May 2022. ID Solutions is now fully independent and heading for their new own projects.

In 2021, ID contributed to the creation of DI4diag: “Deep Intelligence for diagnostics”. This company gathers talents from Montpellier University and the industry. It aims to provide easy-to-use and affordable diagnostics for syndromic infectious diseases, thanks to technologies that combine molecular technics and artificial intelligence. These testing tools will be particularly useful for LMIC.

Health Diagnostics

Life Sciences

Veterinary & Pet

Innovative Diagnostics

Philippe Pourquier

Camille Taliercio

Nathan Bevilacqua

Muriel Malzac

Marine Noguier

Loic Savarit

Laurine Meriau

Judith Sobas

Stephen Ballet

Sandy Garcier

Marie-Elsie Bouvret

Sarah R.

Paul Joseph Coly

Mohssine Kiar

Marie-Esther Pourquier

Gautier Hourdoir

Naomie Vialet

Mathilde Guyard

Herman He

Alix Carpentier

Fabien Donnet

Emmanuelle Cambon

Lorenzo Cecere

Niranjan Kataram

The Research and Development (R&D) team at Innovative Diagnostics focuses on innovating and enhancing diagnostic solutions for zoonotic and veterinary diseases. This multidisciplinary team is responsible for developing new ELISA, PCR, and rapid test products, as well as improving existing technologies to ensure accurate and timely disease detection. Additionally, they collaborate with industry and academic partners to integrate advanced technologies, such as artificial intelligence, into their diagnostic tools, ultimately contributing to the One Health approach and enhancing global health outcomes.

Research and Development

Laboratory and Quality Control

Production and Operations

Research and Development

About

Team members

Other teams at Innovative Diagnostics

Laboratory and Quality Control

Production and Operations